Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Reeve BB, Koch JS, Weis J, Smit EF, van Meerbeeck JP, Bottomley A; EORTC PROBE project and the Lung Cancer Group. Maringwa JT, et al. Among authors: flechtner h. Support Care Cancer. 2011 Nov;19(11):1753-60. doi: 10.1007/s00520-010-1016-5. Epub 2010 Oct 1. Support Care Cancer. 2011. PMID: 20886240
Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D'haese S, Zurlo A. Efficace F, et al. Among authors: flechtner h. J Clin Oncol. 2003 Sep 15;21(18):3502-11. doi: 10.1200/JCO.2003.12.121. J Clin Oncol. 2003. PMID: 12972527 Clinical Trial.
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A; European Organisation for Research and Treatment of Cancer Clinical Groups. Martinelli F, et al. Among authors: flechtner h. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):587-99. doi: 10.1586/erp.11.51. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958103
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Bottomley A. Quinten C, et al. Among authors: flechtner h. J Natl Cancer Inst. 2011 Dec 21;103(24):1851-8. doi: 10.1093/jnci/djr485. Epub 2011 Dec 7. J Natl Cancer Inst. 2011. PMID: 22157640 Free PMC article.
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A; Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups. Quinten C, et al. Among authors: flechtner h. Cancer. 2014 Jan 15;120(2):302-11. doi: 10.1002/cncr.28382. Epub 2013 Oct 11. Cancer. 2014. PMID: 24127333 Free article.
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Machingura A, Taye M, Musoro J, Ringash J, Pe M, Coens C, Martinelli F, Tu D, Basch E, Brandberg Y, Grønvold M, Eggermont A, Cardoso F, Van Meerbeeck J, van der Graaf WTA, Taphoorn M, Reijneveld JC, Soffietti R, Sloan J, Velikova G, Flechtner H, Bottomley A; EORTC Quality of Life Group, Brain tumour, Breast Cancer, Melanoma Group, Lung Cancer, Soft Tissue and Bone Sarcoma, Lymphoma, Gastrointestinal Tract Cancer, Head and Neck Cancer, Genito-Urinary Cancers, and Gynecological Cancer Groups. Machingura A, et al. Among authors: flechtner h. Eur J Cancer. 2022 Jul;170:1-9. doi: 10.1016/j.ejca.2022.03.039. Epub 2022 May 13. Eur J Cancer. 2022. PMID: 35569438 Free article.
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.
Zikos E, Coens C, Quinten C, Ediebah DE, Martinelli F, Ghislain I, King MT, Gotay C, Ringash J, Velikova G, Reeve BB, Greimel E, Cleeland CS, Flechtner H, Taphoorn MJ, Weis J, Schmucker-von Koch J, Sprangers MA, Bottomley A; EORTC PROBE. Zikos E, et al. Among authors: flechtner h. J Natl Cancer Inst. 2015 Dec 28;108(5):djv391. doi: 10.1093/jnci/djv391. Print 2016 May. J Natl Cancer Inst. 2015. PMID: 26714759 Free article. Review.
124 results